About the Event
Don’t miss your opportunity to attend Cannabis Law Institute 2023! Use Code JDSUPRA20 for 20% off!
From June 8th to June 10th, INCBA will host our marquee event at GW Law in Washington, DC.
Register now for a multi-day immersive educational and networking event that puts you in the room with the foremost legal practitioners who support the cannabis industry. Speakers and attendees include policy makers, politicians, and industry thought leaders from around the globe.
Inform your legal practice with over 18 CLE accredited sessions that address key industry issues including:
- Interstate Commerce
- Federal Policy
- State Cannabis Regulation
- International Opportunities
- Overcoming Operational Hurdles
CLI is packed with networking luncheons, off-site parties, and a full reception that creates a custom-tailored experience unique to every year.
Use Code JDSUPRA20 for 20% off!
Description: In practice, policies and the laws created to enforce them, should be rooted in evidence. Research on the impacts of various policy decisions and the behavior or products subject to regulation should drive decision making. However, as we have seen in the cannabis industry, when the underlying research is biased and/or the behavior highly stigmatized and stereotyped, policies and laws may not reflect reality, and in some cases may directly contradict it.
Description Join our panelists for an honest and supportive discussion about harm reduction, stress management, and mental health among attorneys. Learn how to support colleagues in recovery or who are struggling – and how to recognize and manage these challenges in yourself. Discuss how to make colleagues understand that attorney wellness is not merely a buzzword or a generational difference; it is directly related to competence to practice and meeting duties to clients.
Description: This panel will cover issues surrounding the balance that jurisdictions must strike between deploying enforcement as a means to support a regulated market and enacting legislation to support the transition of a legacy market. Presenters will discuss novel ways in which regulators are, or should be, incentivizing legacy and unlicensed operators to transition to the regulated market as opposed to relying heavily on criminal enforcement, which may lead to a War on Drugs 2.0.
